These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1352106)

  • 21. Survival by AIDS defining condition in rural Uganda.
    Morgan D; Malamba SS; Orem J; Mayanja B; Okongo M; Whitworth JA
    Sex Transm Infect; 2000 Jun; 76(3):193-7. PubMed ID: 10961197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
    AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.
    Kovacs A; Frederick T; Church J; Eller A; Oxtoby M; Mascola L
    JAMA; 1991 Apr; 265(13):1698-703. PubMed ID: 1672169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.
    Porter K; Fairley CK; Wall PG; Evans BG; Goldberg DJ; Weerasuriya M; Noone A
    Int J STD AIDS; 1996 Jul; 7(4):252-7. PubMed ID: 8876355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection].
    Miró JM; Buira E; Mallolas J; Gallart T; Moreno A; Zamora L; Vilella R; Gatell JM; Soriano E
    Med Clin (Barc); 1994 Apr; 102(15):566-70. PubMed ID: 7646597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    Am J Epidemiol; 1993 Nov; 138(10):870-8. PubMed ID: 7901990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management.
    Flegg PJ; Brettle RP
    J Infect; 1991 Mar; 22(2):113-8. PubMed ID: 1673989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
    Chaisson RE; Stanton DL; Gallant JE; Rucker S; Bartlett JG; Moore RD
    AIDS; 1993 Jun; 7(6):857-62. PubMed ID: 8103343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of opportunistic infections among HIV-1 infected people in Hong Kong.
    Wong KH; Lee SS; Lo YC; Li PC; Ho HF; Sitt WH; Lam TW; Lai KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Feb; 55(2):127-36. PubMed ID: 7750052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic correlation between CD4-positive T lymphocyte counts and superficial lymphadenopathy in HIV-positive/AIDS patients].
    Lu XC; Deng JN; Huang AC; Li XQ; Mou MH; Ou RZ; Huang L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):622-5. PubMed ID: 22177247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of three clinical case definitions for advanced HIV disease.
    Gallant JE; Somani J; Chaisson RE; Stanton D; Smith M; Quinn TC
    AIDS; 1992 Mar; 6(3):295-9. PubMed ID: 1348946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumocystis carinii pneumonia during primary HIV-1 infection.
    Vento S; Di Perri G; Garofano T; Concia E; Bassetti D
    Lancet; 1993 Jul; 342(8862):24-5. PubMed ID: 8100292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.
    Law MG; de Winter L; McDonald A; Cooper DA; Kaldor JM
    AIDS; 1999 Feb; 13(2):263-9. PubMed ID: 10202833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.